Indefinite Delivery Contract SPE2DX16D2913
- Not listed
- This federal Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a comprehensive pharmaceutical and medical supply contract valued at up to $4,999,999.99. The contract runs through December 31, 2025 and covers a wide range of essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple...
- The federal contract IDV award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $999,999,999.00 Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, which runs through December 31, 2025, serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses critical medical commodities...
- This Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., aims to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The single-award IDC, valued at up to $999,999,999.00, serves as the primary vehicle for delivering essential medical commodities including specialty medications, brand-name and generic...
- The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a critical vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The $999,999,999 single-award IDC, which runs through November 2026, encompasses the delivery of specialty medications, brand-name and generic drugs, vaccines, syringes,...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $4,999,999.99, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has an ultimate completion date of December 31, 2025. The IDC serves as the primary vehicle for Amerisourcebergen to...
- This Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $4,999,999.00 and runs through December 31, 2025. The contract provides for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The task orders under this IDC cover a variety of critical medical commodities, including...
- The provided information describes an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The single-award IDC, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense (DoD) worldwide. The...
- The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp. is a single-award contract valued at $999,999,999 through November 2026. This contract serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses a broad spectrum of critical medical commodities, including...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a single-award Indefinite Delivery Contract (IDC) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The $999,999,999 IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. Under this IDC, the DLA has issued numerous firm fixed-price...
- This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contracted items include specialty...
This Indefinite Delivery Contract (IDC) award from the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is valued at up to $4,999,999.99 through December 31, 2025. The contract provides for the delivery of a broad range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas such as cardiovascular health, diabetes management, mental health, pain management, and infectious disease prevention. The IDC serves as the primary contracting vehicle for DLA to efficiently procure these essential medical commodities for military treatment facilities, veterans' healthcare programs, and other federal medical institutions. In addition to this DLA IDC, Amerisourcebergen also holds a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation through May 2024, covering similar pharmaceutical and medical supply products. These IDCs demonstrate Amerisourcebergen's extensive capabilities in pharmaceutical distribution and its critical role as a key vendor for federal healthcare programs, particularly within the Department of Defense and Department of Veterans Affairs. The contracts were awarded through full and open competition without any set-aside requirements, reflecting the company's strong position in the market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/3/16 |